Filing Details

Accession Number:
0001493152-24-031439
Form Type:
4
Zero Holdings:
No
Publication Time:
2024-08-12 21:58:49
Reporting Period:
2024-08-12
Accepted Time:
2024-08-12 21:58:49
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1958777 Fibrobiologics Inc. FBLG () 4
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1569334 Pete O'heeron C/O Fibrobiologics, Inc.
455 E. Medical Center Blvd. Suite 300
Houston TX 77598
Chief Executive Officer Yes Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2024-08-12 8,500 $1.91 6,056,647 No 4 P Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Direct
Footnotes
  1. The price reported in Column 4 is a weighted average price. These shares were purchased in multiples transactions ranging from $1.82 to $2.017 on August 12, 2024. The reporting person will provide upon request to the SEC, the issuer, or security holder of the Issuer, full information regarding the number of shares purchased at each separate price.